TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06213974 updates: 1. completion date: 2026-09-01 → 2026-07-31 2. primary completion date: 2026-06-01 → 2026-07-31
Clinical trial NCT06213974 updates: 1. completion date: 2026-09-01 → 2026-07-31 2. primary completion date: 2026-06-01 → 2026-07-31
Clinical trial NCT04189614 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-05-01 → 2026-05-07 3. primary completion date: 2026-05-01 → 2026-05-07
Clinical trial NCT05878951 updates: 1. completion date: 2026-08-24 → 2026-12-31 2. primary completion date: 2026-06-01 → 2026-09-01
Clinical trial NCT06052631: start date: 2026-06-08 → 2026-06-09.
Clinical trial NCT05516537 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-01-30 3. primary completion date: 2025-12-01 → 2025-12-31 4. enrollment: 100 → 121 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04722835 updates: 1. status: UNKNOWN → RECRUITING 2. completion date: 2022-12-31 → 2030-12-31 3. primary completion date: 2022-12-31 → 2030-12-31
Clinical trial NCT06973109 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. start date: 2026-03-20 → 2026-06-20 3. enrollment: 36 → 0 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04287621: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT04176172 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-08-31 → 2026-11-30 3. primary completion date: 2026-08-31 → 2026-11-30
Clinical trial NCT06393946: primary completion date: 2026-04-28 → 2026-07-31.